Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,270,773
-$443,707 QoQ
Shares Held
52,773
-13.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,180
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
This page
|
52,773 | $1,270,773 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,270,773 | 52,773 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,714,480 | 61,057 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,448,425 | 138,491 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,258,000 | 127,865 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,841,267 | 117,214 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,819,429 | 111,264 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,931,909 | 110,513 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,126,475 | 108,033 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,976,204 | 106,369 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,826,726 | 101,864 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,818,483 | 97,898 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,923,471 | 88,136 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,185,768 | 86,853 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,516,348 | 86,185 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $4,413,249 | 86,129 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,614,882 | 82,607 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,430,964 | 84,512 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $4,335,685 | 83,749 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $4,707,761 | 79,725 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $3,159,471 | 73,459 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $2,585,852 | 66,033 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $2,386,904 | 65,882 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,252,624 | 61,196 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,164,527 | 58,979 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,903,959 | 58,225 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,282,348 | 69,925 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||